• Je něco špatně v tomto záznamu ?

Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders

M. Wayhelova, V. Vallova, P. Broz, A. Mikulasova, J. Smetana, H. Dynkova Filkova, D. Machackova, K. Handzusova, R. Gaillyova, P. Kuglik

. 2024 ; 19 (1) : 41. [pub] 20240206

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007193

Grantová podpora
NU20-07-00145 Ministerstvo Zdravotnictví Ceské Republiky

BACKGROUND: Neurodevelopmental disorders (NDDs) and/or associated multiple congenital abnormalities (MCAs) represent a genetically heterogeneous group of conditions with an adverse prognosis for the quality of intellectual and social abilities and common daily functioning. The rapid development of exome sequencing (ES) techniques, together with trio-based analysis, nowadays leads to up to 50% diagnostic yield. Therefore, it is considered as the state-of-the-art approach in these diagnoses. RESULTS: In our study, we present the results of ES in a cohort of 85 families with 90 children with severe NDDs and MCAs. The interconnection of the in-house bioinformatic pipeline and a unique algorithm for variant prioritization resulted in a diagnostic yield of up to 48.9% (44/90), including rare and novel causative variants (41/90) and intragenic copy-number variations (CNVs) (3/90). Of the total number of 47 causative variants, 53.2% (25/47) were novel, highlighting the clinical benefit of ES for unexplained NDDs. Moreover, trio-based ES was verified as a reliable tool for the detection of rare CNVs, ranging from intragenic exon deletions (GRIN2A, ZC4H2 genes) to a 6-Mb duplication. The functional analysis using PANTHER Gene Ontology confirmed the involvement of genes with causative variants in a wide spectrum of developmental processes and molecular pathways, which form essential structural and functional components of the central nervous system. CONCLUSION: Taken together, we present one of the first ES studies of this scale from the central European region. Based on the high diagnostic yield for paediatric NDDs in this study, 48.9%, we confirm trio-based ES as an effective and reliable first-tier diagnostic test in the genetic evaluation of children with NDDs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007193
003      
CZ-PrNML
005      
20240423155800.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13023-024-03056-6 $2 doi
035    __
$a (PubMed)38321498
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Wayhelova, Marketa $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. marketa.wayhelova@mail.muni.cz $u Centre of Molecular Biology and Genetics, University Hospital Brno, Brno, Czech Republic. marketa.wayhelova@mail.muni.cz $1 https://orcid.org/0000000304758890 $7 mub20231183466
245    10
$a Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders / $c M. Wayhelova, V. Vallova, P. Broz, A. Mikulasova, J. Smetana, H. Dynkova Filkova, D. Machackova, K. Handzusova, R. Gaillyova, P. Kuglik
520    9_
$a BACKGROUND: Neurodevelopmental disorders (NDDs) and/or associated multiple congenital abnormalities (MCAs) represent a genetically heterogeneous group of conditions with an adverse prognosis for the quality of intellectual and social abilities and common daily functioning. The rapid development of exome sequencing (ES) techniques, together with trio-based analysis, nowadays leads to up to 50% diagnostic yield. Therefore, it is considered as the state-of-the-art approach in these diagnoses. RESULTS: In our study, we present the results of ES in a cohort of 85 families with 90 children with severe NDDs and MCAs. The interconnection of the in-house bioinformatic pipeline and a unique algorithm for variant prioritization resulted in a diagnostic yield of up to 48.9% (44/90), including rare and novel causative variants (41/90) and intragenic copy-number variations (CNVs) (3/90). Of the total number of 47 causative variants, 53.2% (25/47) were novel, highlighting the clinical benefit of ES for unexplained NDDs. Moreover, trio-based ES was verified as a reliable tool for the detection of rare CNVs, ranging from intragenic exon deletions (GRIN2A, ZC4H2 genes) to a 6-Mb duplication. The functional analysis using PANTHER Gene Ontology confirmed the involvement of genes with causative variants in a wide spectrum of developmental processes and molecular pathways, which form essential structural and functional components of the central nervous system. CONCLUSION: Taken together, we present one of the first ES studies of this scale from the central European region. Based on the high diagnostic yield for paediatric NDDs in this study, 48.9%, we confirm trio-based ES as an effective and reliable first-tier diagnostic test in the genetic evaluation of children with NDDs.
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a sekvenování exomu $7 D000073359
650    _2
$a molekulární patologie $7 D057089
650    12
$a neurovývojové poruchy $x genetika $7 D065886
650    12
$a mnohočetné abnormality $7 D000015
650    _2
$a variabilita počtu kopií segmentů DNA $7 D056915
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vallova, Vladimira $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u Centre of Molecular Biology and Genetics, University Hospital Brno, Brno, Czech Republic
700    1_
$a Broz, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Mikulasova, Aneta $u Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK
700    1_
$a Smetana, Jan $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Dynkova Filkova, Hana $u Centre of Molecular Biology and Genetics, University Hospital Brno, Brno, Czech Republic
700    1_
$a Machackova, Dominika $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Handzusova, Kristina $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Gaillyova, Renata $u Department of Medical Genetics and Genomics, University Hospital Brno, Brno, Czech Republic
700    1_
$a Kuglik, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u Centre of Molecular Biology and Genetics, University Hospital Brno, Brno, Czech Republic
773    0_
$w MED00165365 $t Orphanet journal of rare diseases $x 1750-1172 $g Roč. 19, č. 1 (2024), s. 41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38321498 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155756 $b ABA008
999    __
$a ok $b bmc $g 2081276 $s 1216960
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 1 $d 41 $e 20240206 $i 1750-1172 $m Orphanet journal of rare diseases $n Orphanet J Rare Dis $x MED00165365
GRA    __
$a NU20-07-00145 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace